Proton Radiotherapy to Reduce Late Complications in Childhood Head and Neck Cancers

• Main Authors: Michael T. Spiotto, MD, PhD, Susan L. McGovern, MD, PhD, G. Brandon Gunn, MD, David Grosshans, MD, Mary Frances McAleer, MD, PhD, Steven J. Frank, MD, Arnold C. Paulino, MD
• Format: Article
• Language: English
• Published: Particle Therapy Co-operative Group 2021-06-01
• Series: International Journal of Particle Therapy
• Subjects: radiotherapy; radiotherapy, intensity-modulated; proton therapy; neoplasms, radiation-induced
• Online Access: https://theijpt.org/doi/pdf/10.14338/IJPT-20-00069.1

In most childhood head and neck cancers, radiotherapy is an essential component of treatment; however, it can be associated with problematic long-term complications. Proton beam therapy is accepted as a preferred radiation modality in pediatric cancers to minimize the late radiation side effects. Given that childhood cancers are a rare and heterogeneous disease, the support for proton therapy comes from risk modeling and a limited number of cohort series. Here, we discuss the role of proton radiotherapy in pediatric head and neck cancers with a focus on reducing radiation toxicities. First, we compare the efficacy and expected toxicities in proton and photon radiotherapy for childhood cancers. Second, we review the benefit of proton radiotherapy in reducing acute and late radiation toxicities, including risks for secondary cancers, craniofacial development, vision, and cognition. Finally, we review the cost effectiveness for proton radiotherapy in pediatric head and neck cancers. This review highlights the benefits of particle radiotherapy for pediatric head and neck cancers to improve the quality of life in cancer survivors, to reduce radiation morbidities, and to maximize efficient health care use.